The cardiovascular actions of anandamide: more targets?
Randall
Michael D
MD
School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH. michael.randall@nottingham.ac.uk
D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D063388:Endocannabinoids; D006439:Hemodynamics / Q000187:drug effects*; D053284:Polyunsaturated Alkamides; D051381:Rats; D043882:Receptors, Cannabinoid / Q000187:drug effects
D001095:Arachidonic Acids; D002121:Calcium Channel Blockers; D063388:Endocannabinoids; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; C078814:anandamide